Skip to main content
ENCell Co., Ltd. logo

ENCell Co., Ltd. — Investor Relations & Filings

Ticker · 456070 ISIN · KR7456070002 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2024-08-30 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 456070

About ENCell Co., Ltd.

http://www.encellinc.com/en/

ENCell Co., Ltd. is a biopharmaceutical company specializing in advanced cell and gene therapies (CGT). The company's primary focus is providing Contract Development and Manufacturing Organization (CDMO) services, supported by globally recognized GMP facilities. Its offerings include process development, manufacturing, and contract quality testing (CQT) for a diverse portfolio of advanced therapies, including MSC, CAR-T, CAR-NK, and iPSC-derived cell therapies. ENCell leverages proprietary technologies such as the ROCKET Platform for multi-product GMP production and a next-generation stem cell platform designed to enhance yield and efficacy. In addition to its CDMO business, the company develops its own therapeutic pipeline. This internal research and development focuses on next-generation stem cell treatments, cancer immunotherapy, and AAV-based gene therapies, with a program for Duchenne Muscular Dystrophy in development.

Recent filings

Filing Released Lang Actions
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the exercise of stock options (주식매수선택권 행사) by employees of the company 'EnCell'. It details the number of shares exercised, the exercise price, the impact on total shares, and the remaining stock options. This type of disclosure regarding changes in capital structure due to stock option exercises falls under the 'Share Issue/Capital Change' category.
2024-08-30 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the acquisition and subsequent disposal of shares in 'ENCELL Co., Ltd.' by Kolon Investment and its related investment funds. This type of filing is a standard regulatory requirement for entities crossing significant ownership thresholds, which falls under the 'Major Shareholding Notification' category.
2024-08-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. This type of filing is a standard regulatory requirement in South Korea for entities that acquire a significant stake (typically 5% or more) in a publicly traded company. It details the reporting entity, the number of shares held, the purpose of the holding (in this case, simple investment), and any changes in shareholding. This falls under the category of 'Major Shareholding Notification'.
2024-08-29 Korean
기타경영사항(자율공시) (전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from ENCELL regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure (share issuance and conversion). According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2024-08-26 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the final results of a public offering, including subscription and allocation data, share issuance details, and the use of proceeds. It is a standard regulatory filing required after a company completes an IPO or capital raise. Since it reports the actual results of a securities issuance rather than just an announcement of the report, it falls under the 'Share Issue/Capital Change' category.
2024-08-16 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement - Amendment) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the offering price (공모가액 확정) for Encell Co., Ltd. (이엔셀 주식회사). This type of regulatory filing, which details the terms of a public offering and capital raising, falls under the 'Regulatory Filings' category as it is a formal submission to a financial regulator regarding securities issuance.
2024-08-09 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.